Home / Levetiracetam / Canada
CA ATC N03AX14 · updated 2 Nov 2026
Levetiracetam shortage in Canada
Is there a Levetiracetam shortage in Canada?
Yes. As of 2 Nov 2026, 15 Levetiracetam products are reported short in Canada, the first since 1 Apr 2018. The company estimate for the return is 4 Dec 2026 (latest 18 Dec 2026). Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Austria, Czechia, Sweden, Japan, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | BIO-LEVETIRACETAM (120) | BIOMED PHARMA | 1 Apr 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | BIO-LEVETIRACETAM (120) | BIOMED PHARMA | 1 Apr 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | LEVETIRACETAM (120) | LABORATOIRE RIVA INC | 5 Oct 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | BIO-LEVETIRACETAM (120) | BIOMED PHARMA | 31 Dec 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | M-LEVETIRACETAM (120) | MANTRA PHARMA INC | 19 Feb 2024 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | M-LEVETIRACETAM (120) | MANTRA PHARMA INC | 19 Feb 2024 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | ACH-LEVETIRACETAM (120) | ACCORD HEALTHCARE INC | 28 Jun 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | ACH-LEVETIRACETAM (120) | ACCORD HEALTHCARE INC | 21 Mar 2025 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | NAT-LEVETIRACETAM (120 BTL) | NATCO PHARMA (CANADA) INC | 8 Apr 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACH-LEVETIRACETAM (120) | ACCORD HEALTHCARE INC | 20 Jun 2025 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | NAT-LEVETIRACETAM (120 BTL) | NATCO PHARMA (CANADA) INC | 1 Jul 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NAT-LEVETIRACETAM (120 BTL) | NATCO PHARMA (CANADA) INC | 1 Jul 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-LEVETIRACETAM (100 BTL) | APOTEX INC | 13 Oct 2026 | 18 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-LEVETIRACETAM (100 BTL) | APOTEX INC | 19 Oct 2026 | 4 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-LEVETIRACETAM (100 BTL) | APOTEX INC | 27 Oct 2026 | 4 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.